News for Medpace Holdings, Inc. (MEDP.MX)

Q4 2024 Revenue: $536.6 million, a year-over-year increase of 7.7%.Full-Year 2024 Revenue: $2.11 billion, an 11.8% increase from 2023.Q4 2024 EBITDA: $133.5 mi

Medpace Holdings, Inc. (NASDAQ:MEDP) Q4 2024 Earnings Conference Call February 11, 2025 9:00 AM ETCompany ParticipantsLauren Morris - Director, Investor...

The following slide deck was published by Medpace Holdings, Inc.

U.S. stock futures were lower this morning, with the Nasdaq futures falling around 100 points on Tuesday. Shares of Harmonic Inc. HLIT fell sharply in today's ...

Shares of Medpace Holdings Inc (MEDP) surged 3.46% in mid-day trading on Jan 21. The stock reached an intraday high of $349.29, before settling at $349.03,

Focus and Focus Plus were our best performing strategies during the fourth quarter and the year. Read more here.

Shares of Medpace Holdings Inc (MEDP) fell 5.64% in mid-day trading on Jan 14. The stock reached an intraday low of $329.06, before recovering slightly to $33

Summary Medpace Holdings Inc (MEDP), a global clinical contract research organization, has announced that it will release its fourth quarter and fiscal year 202

Shares of Medpace Holdings Inc (MEDP) surged 3.55% in mid-day trading on Nov 25. The stock reached an intraday high of $350.10, before settling at $349.75,

Shares of Medpace Holdings Inc (MEDP) surged 3.19% in mid-day trading on Nov 20. The stock reached an intraday high of $325.88, before settling at $324.99,

Shares of Medpace Holdings Inc (MEDP) surged 4.22% in mid-day trading on Nov 8. The stock reached an intraday high of $369.85, before settling at $368.33, u

Shares of Medpace Holdings Inc (MEDP) surged 3.23% in mid-day trading on Nov 6. The stock reached an intraday high of $328.94, before settling at $328.24, u

In the fast-paced and highly competitive business world of today, conducting thorough company analysis is essential for investors and industry observers. In thi...

NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating...

Texas-based Genprex, Inc. (GNPX), a clinical-stage gene therapy company is up over 103 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Shares of iRhythm Technologies, Inc. IRTC rose sharply in today's pre-market trading after the company announced that it was granted FDA clearance for its 510(k...

CHARLOTTE, N.C., Aug. 16, 2024 (GLOBE NEWSWIRE) -- Glatfelter Corporation (NYSE: GLT), and Berry Global Group, Inc. (NYSE: BERY) today announce...

Despite economic growth slowing in the second quarter, there are reasons to feel cautiously optimistic.

Shares of SAP SE SAP rose sharply in today's pre-market trading after the company reported second-quarter financial results. SAP reported quarterly earnings of...